AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read

Casteel Julie K sold $706K of IBEX

Casteel Julie K (Chief Sales/Marketing Officer) sold 17,474 shares of IBEX Ltd (IBEX) at $40.41 ($0.71M total) on 2026-09-15.

Original reporting
SEC EDGAR · Casteel Julie K
Published Sep 16, 2026, 9:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$IBEX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The transaction reduces the insider's stake but leaves a sizable holding; unlikely to move the stock.

02

Market read

Routine insider sale with modest dollar amount; limited trading relevance.

03

What to watch

No material impact on the company's operations; insider ownership remains substantial.

Relevance 5/10Novelty 4/10Timing: sale dated 2026-09-15, filed 2026-09-16

Background

Form 4 filing reporting a C-suite officer's open‑market sale of 17,474 shares at $40.41 each.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

The sale may be viewed as a lack of confidence, but could simply be portfolio rebalancing.

Key entities

  • company
    IBEX Ltd

    Issuer of the Form 4 filing.

  • person
    Julie K. Casteel

    Chief Sales/Marketing Officer and reporting insider.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IBEX insider trading history →

Related articles

SEP 13
$IBEXHighAI 8/10

IBEX (IBEX) Turns The AI Threat Into Its Biggest Growth Engine

IBEX (IBEX) reported record full-year revenue of $644.1M, up 15.4%, and Q4 revenue of $164.3M, up 11.6%. Growth was driven by HealthTech, Technology, and Travel & Logistics. AI partnerships with Philippine Airlines and BJ's Wholesale showed strong results. Q4 net income fell to $8.7M, and EPS dropped to $0.59 due to training and operational costs.

yahoo.com2 min
SEP 11
$IBEXMedAI 8/10

IBEX (IBEX) Q4 2026 Earnings Call Transcript

IBEX (IBEX) reported fiscal year 2026 revenue of $644.1 million, up 15.4%, with Q4 revenue at $164.3 million, up 11.6%. Adjusted EBITDA reached $82.4 million, a 14.5% increase. HealthTech revenue grew 38.5% to $114 million. Guidance for 2027 projects revenue of $700M-$715M and adjusted EBITDA of $90M-$94M. The company highlighted growth in AI-powered services and strategic partnerships.

aol.com2 min
SEP 10
$IBEXHigh

IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance

IBEX Ltd (IBEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth • Nine new logo wins in the fourth quarter, including two

SEC EDGAR 8-K3 min